Population Pharmacokinetics of Caspofungin and Dosing Optimization in Children With Allogeneic Hematopoietic Stem Cell Transplantation

Caspofungin is the first echinocandin antifungal agent that licented for pediatric use in invasive candidiasis and aspergillosis. In this study, we evaluated the population pharmacokinetics of caspofungin and investigate appropriate dosing optimization against Candida spp. in children with allogenei...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Chang-He, Xu, Hua, Gao, Liu-Liu, Nie, Ying-Ming, Xing, Li-Peng, Yu, Li-Peng, Wu, San-Lan, Wang, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061854/
https://www.ncbi.nlm.nih.gov/pubmed/32194415
http://dx.doi.org/10.3389/fphar.2020.00184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061854/
https://www.ncbi.nlm.nih.gov/pubmed/32194415
http://dx.doi.org/10.3389/fphar.2020.00184

Ejemplares similares